Current portfolio

Nkarta

US biotech company developing engineered natural killer (NK) cell therapies

  • Sektor
    Healthcare
  • Land
    United States
  • Fond
    LSP 6
  • Entry
    2019
  • Web
Logo

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180